Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Sheinin

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nature Methods|March 18, 2025
scNET: learning context-specific gene and cell embeddings by integrating single-cell gene expression data with protein-protein interactionsRon Sheinin, Roded Sharan, Asaf Madi
NPJ Systems Biology and Applications|June 10, 2024
interFLOW: maximum flow framework for the identification of factors mediating the signaling convergence of multiple receptorsRon Sheinin, Koren Salomon, Eilam Yeini, et al.
Nature Communications|March 27, 2021
P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progressionEilam Yeini, Paula Ofek, Sabina Pozzi, et al.
Cancer Cell|January 13, 2023
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumorsMichael Kilian, Ron Sheinin, Chin Leng Tan, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nature Methods|March 18, 2025
scNET: learning context-specific gene and cell embeddings by integrating single-cell gene expression data with protein-protein interactionsRon Sheinin, Roded Sharan, Asaf Madi
NPJ Systems Biology and Applications|June 10, 2024
interFLOW: maximum flow framework for the identification of factors mediating the signaling convergence of multiple receptorsRon Sheinin, Koren Salomon, Eilam Yeini, et al.
Nature Communications|March 27, 2021
P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progressionEilam Yeini, Paula Ofek, Sabina Pozzi, et al.
Cancer Cell|January 13, 2023
MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumorsMichael Kilian, Ron Sheinin, Chin Leng Tan, et al.
Pageof 1